Cargando…
Pharmaceutical markets and insurance worldwide /
The fields of pharmaceutical economics and health economics/policy are reaching a point of convergence. This is due to both the widespread availability of pharmaceutical treatments, accompanied by broader insurance coverage, and the regulation of prescription drugs in both private and government pla...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Bingley, UK :
Emerald/JAI,
2010.
|
| Edición: | 1st ed. |
| Colección: | Advances in health economics and health services research ;
v. 22. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | ocn649478955 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 100721s2010 enka ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d IDEBK |d OCLCQ |d CDX |d E7B |d OCLCQ |d UWO |d OCLCQ |d BWS |d OCLCO |d OCLCF |d NLGGC |d OCLCO |d BEDGE |d OCLCQ |d SUF |d AGLDB |d KIJ |d OCLCO |d JBG |d OCLCO |d OCLCQ |d VTS |d OCLCA |d REC |d OCLCO |d OCLCA |d S9I |d STF |d M8D |d OCLCO |d OCLCQ | ||
| 019 | |a 651129060 |a 738739347 |a 823930033 |a 964597717 |a 1167148570 | ||
| 020 | |a 9781849507172 |q (electronic bk.) | ||
| 020 | |a 1849507171 |q (electronic bk.) | ||
| 020 | |a 9781849507165 |q (hbk.) | ||
| 020 | |a 1849507163 |q (hbk.) | ||
| 024 | 8 | |a 9786612526329 | |
| 029 | 1 | |a AU@ |b 000051005308 | |
| 029 | 1 | |a CDX |b 12899435 | |
| 029 | 1 | |a DEBBG |b BV043116375 | |
| 029 | 1 | |a DEBSZ |b 421871512 | |
| 029 | 1 | |a NZ1 |b 15570812 | |
| 035 | |a (OCoLC)649478955 |z (OCoLC)651129060 |z (OCoLC)738739347 |z (OCoLC)823930033 |z (OCoLC)964597717 |z (OCoLC)1167148570 | ||
| 037 | |a 252632 |b MIL | ||
| 050 | 4 | |a HD9665.5 |b .P53 2010eb | |
| 060 | 4 | |a W1 |b AD621T v.22 2010 | |
| 060 | 4 | |a QV 736 | |
| 072 | 7 | |a BUS |x 070080 |2 bisacsh | |
| 080 | |a 615 | ||
| 082 | 0 | 4 | |a 338.47615 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Pharmaceutical markets and insurance worldwide / |c edited by Avi Dor. |
| 250 | |a 1st ed. | ||
| 260 | |a Bingley, UK : |b Emerald/JAI, |c 2010. | ||
| 300 | |a 1 online resource (xxi, 344 pages) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 490 | 1 | |a Advances in health economics and health services research, |x 0731-2199 ; |v v. 22 | |
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | 0 | |g Part I: International reviews -- |t Pharmaceutical policies in European countries / |r Pedro Pita Barros -- |t International experience with comparative effectiveness research : case studies from England/Wales and Germany / |r John F.P. Bridges [and others] -- |g Part II: National case studies -- |t Pharmaceutical policy in the Netherlands : from price regulation towards managed competition / |r Lieke H.H.M. Boonen [and others] -- |t Impact of pharmaceutical regulation and policies on health system performance goals in israel / |r Philip Sax and Amir Shmueli -- |t Global budgets and provider incentives : hospitals' drug expenditures in Taiwan / |r Shin-Yi Chou [and others] -- |t Medicare Part D turns four : trends in plan design, enrollment, and the impact of the program on beneficiaries / |r Jack Hoadley and Kosali Simon -- |g Part III: U.S. studies : from markets to policy innovations -- |t Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes / |r William E. Encinosa, Didem Bernard and Avi Dor -- |t Cost shring, benefit design, and adherence : the case of multiple sclerosis / |r Avi Dor [and others] -- |t Generic utilization and cost-sharing for prescription drugs / |r Teresa Bernard Gibson, Catherine G. McLaughlin and Dean G. Smith -- |t Drug prices, out-of-pocket payments, and insurer costs : how do payers vary? / |r Jie Chen and John A. Rizzo -- |t Adverse selection and the effect of health insurance on utilization of prescribed medicine among patients with chronic conditions / |r Yuriy Pylypchuk -- |t The effect of drug vintage on survival : micro evidence from Puerto Rico's Medicaid program / |r Frank R. Lichtenberg -- |g Part IV: Special topics -- |t Retail pharmacy market structure and insurer-independent pharmacy bargaining in the Medicare Part D era / |r Yang Xie [and others] -- |t Patents, innovation, and the welfare effects of Medicare Part D / |r Adam Gailey, Darius Lakdawalla and Neeraj Sood. |
| 588 | 0 | |a Print version record. | |
| 520 | |a The fields of pharmaceutical economics and health economics/policy are reaching a point of convergence. This is due to both the widespread availability of pharmaceutical treatments, accompanied by broader insurance coverage, and the regulation of prescription drugs in both private and government plans. This book will bridge the gap. We will explore developments in both U.S. and International setting. The system of the U.S. is characterized by a mix of private and government insurance for prescription drugs with the expansion of Medicare Part D. Most other developed countries are characterized by social insurance with either the government as a single payer such as in Canada or Australia, or a national health service as in many other European countries. | ||
| 590 | |a Emerald Insight |b Emerald All Book Titles | ||
| 650 | 0 | |a Pharmaceutical industry |x Economic aspects. | |
| 650 | 0 | |a Medical economics. | |
| 650 | 0 | |a Health insurance |x Finance. | |
| 650 | 0 | |a Health insurance |x Costs. | |
| 650 | 2 | |a Drug Industry |x economics | |
| 650 | 2 | |a Economics, Medical | |
| 650 | 2 | |a Insurance, Health |x economics | |
| 650 | 6 | |a Industrie pharmaceutique |x Aspect économique. | |
| 650 | 6 | |a Économie de la santé. | |
| 650 | 7 | |a Health economics. |2 bicssc | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x Service. |2 bisacsh | |
| 650 | 7 | |a Gestion d'entreprises. |2 eclas | |
| 650 | 7 | |a Health insurance |x Costs. |2 fast |0 (OCoLC)fst01725518 | |
| 650 | 7 | |a Health insurance |x Finance. |2 fast |0 (OCoLC)fst01715843 | |
| 650 | 7 | |a Medical economics. |2 fast |0 (OCoLC)fst01014004 | |
| 650 | 7 | |a Pharmaceutical industry |x Economic aspects. |2 fast |0 (OCoLC)fst01060138 | |
| 700 | 1 | |a Dor, Avi, |d 1956- | |
| 776 | 0 | 8 | |i Print version: |t Pharmaceutical markets and insurance worldwide. |b 1st ed. |d Bingley, UK : Emerald/JAI, 2010 |z 9781849507165 |w (OCoLC)502423752 |
| 830 | 0 | |a Advances in health economics and health services research ; |v v. 22. | |
| 856 | 4 | 0 | |u https://emerald.uam.elogim.com/insight/publication/doi/10.1108/S0731-2199(2010)22 |z Texto completo |
| 938 | |a Coutts Information Services |b COUT |n 12899435 | ||
| 938 | |a ebrary |b EBRY |n ebr10381745 | ||
| 938 | |a EBSCOhost |b EBSC |n 318261 | ||
| 994 | |a 92 |b IZTAP | ||